Pharmaceuticals, Biotechnology and Life Sciences
-Approval Triggers Milestone Payment and Royalties on Worldwide Net Sales- BOTHELL, Wash.–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) today announced U.S. Food…
-Approval Triggers Milestone Payment and Royalties on Worldwide Net Sales- BOTHELL, Wash.–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) today announced U.S. Food…
– New targeted medicine shown to improve clinical outcomes in people with relapsed or refractory diffuse large B-cell lymphoma compared…
– New targeted medicine shown to improve clinical outcomes in people with relapsed or refractory diffuse large B-cell lymphoma compared…
Establishes Working Group with the FDA on Nonclinical Initiatives PHILADELPHIA–(BUSINESS WIRE)–BioCelerate, a subsidiary of TransCelerate BioPharma Inc., today announced a…
Common concentration now available exclusively in FDA-approved ready-to-administer prefilled syringe LAKE ZURICH, Ill.–(BUSINESS WIRE)–Fresenius Kabi announced today the immediate availability…
DUBLIN–(BUSINESS WIRE)–The “Cell Based Assay & High Content Screening Markets – Market Forecasts by Application With Executive and Consultant Guides…
OAKLAND, Calif.–(BUSINESS WIRE)–#biotechnology–OrthoTrophix, Inc. (www.orthotrophix.com), a privately-held biopharmaceutical company, announced today new results from a Phase 2 study of the osteoarthritis drug TPX-100.…
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–#INDstatus—PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for…
VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE American: CVM) is set to join the broad-market Russell 3000® Index at the conclusion of…